Discordant association of nonalcoholic fatty liver disease with lipoprotein(a) and markers of atherogenic dyslipidemia
Journal of Clinical Lipidology · 2023
DOI: 10.1016/j.jacl.2023.09.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Lipidology, 2023. Verfasst von Anurag Mehta und 7 weiteren Autor:innen. Beteiligte Einrichtung: Virginia Commonwealth University Health Pauley Heart Center, Richmond, Virginia (Drs Mehta, Lee, Alebna, Grandhi, Dixon, and Salloum). Electronic add…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Dyslipidemias. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: National Institute on Alcohol Abuse and Alcoholism, Gilead Sciences.
Abstract (Originalsprache)
Nonalcoholic fatty liver disease (NAFLD) is associated with atherogenic dyslipidemia and an increased risk of cardiovascular events. Previous studies have suggested an inverse relationship between NAFLD severity and lipoprotein(a) [Lp(a)] level, but contemporary data from the U.S. are lacking. Lp(a), lipid profile, apolipoproteins, and nuclear magnetic resonance-based lipoprotein particle concentrations were measured in 151 patients with biopsy-proven NAFLD. Levels were compared between those with nonalcoholic fatty liver (NAFL) on histology and non-alcoholic steatohepatitis (NASH). Median age was 55 [48, 62] years, 67% of patients were women, 83% were White, 43% had NAFL, and 57% had NASH. Triglyceride level was higher and high-density lipoprotein-cholesterol (HDL-C) was lower among those with NASH as compared with NAFL. Circulating apolipoprotein-B (ApoB) and low-density lipoprotein particle concentration (LDL-P) were 9% and 17% higher in the NASH group as compared with NAFL, respectively. Contrastingly, Lp(a) concentration was 50% lower in NASH relative to NAFL group. Hepatocyte ballooning, lobular inflammation, and fibrosis on histology were inversely associated with Lp(a) concentration. NAFLD severity has a discordant association with Lp(a) and other markers of atherogenic dyslipidemia. This relationship may have implications for prognosticating cardiovascular disease risk in patients with NAFLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Virginia Commonwealth University Health Pauley Heart Center, Richmond, Virginia (Drs Mehta, Lee, Alebna, Grandhi, Dixon, and Salloum). Electronic address: anurag.mehta@vcuhealth.org.
- Virginia Commonwealth University Health Pauley Heart Center, Richmond, Virginia (Drs Mehta, Lee, Alebna, Grandhi, Dixon, and Salloum).
- Virginia Commonwealth University Health Pauley Heart Center, Richmond, Virginia (Drs Mehta, Lee, Alebna, Grandhi, Dixon, and Salloum); Virginia Commonwealth University School of Pharmacy, Richmond, Virginia (Dr Dixon).
- Stravitz-Sanyal Liver Institute, Virginia Commonwealth University, Richmond, Virginia (Drs Sanyal and Siddiqui).
Förderung
- National Institute on Alcohol Abuse and Alcoholism
- Gilead Sciences
Zitieren
APA
Mehta, A., Lee, T. B., Alebna, P., Grandhi, G. R., Dixon, D. L., Salloum, F. N., Sanyal, A. J., & Siddiqui, M. S. (2023). Discordant association of nonalcoholic fatty liver disease with lipoprotein(a) and markers of atherogenic dyslipidemia. Journal of Clinical Lipidology. https://doi.org/10.1016/j.jacl.2023.09.003
Vancouver
Mehta A, Lee TB, Alebna P, Grandhi GR, Dixon DL, Salloum FN, et al. Discordant association of nonalcoholic fatty liver disease with lipoprotein(a) and markers of atherogenic dyslipidemia. Journal of Clinical Lipidology. 2023. doi:10.1016/j.jacl.2023.09.003
BibTeX
@article{Mehta2023,
author = {Mehta, Anurag and Lee, Terence B and Alebna, Pamela and Grandhi, Gowtham R and Dixon, Dave L and Salloum, Fadi N and Sanyal, Arun J and Siddiqui, Mohammad S},
title = {Discordant association of nonalcoholic fatty liver disease with lipoprotein(a) and markers of atherogenic dyslipidemia},
journal = {Journal of Clinical Lipidology},
year = {2023},
doi = {10.1016/j.jacl.2023.09.003}
}
EUVIMED